Biohaven (BHVN) Cash & Current Investments (2021 - 2026)

Biohaven (BHVN) has 6 years of Cash & Current Investments data on file, last reported at $347.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 7.77% year-over-year to $347.8 million; the trailing twelve-month figure through Mar 2026 stood at $347.8 million (up 7.77% YoY), and the FY2025 full-year result was $319.1 million, down 34.33% from the prior year.
• Cash & Current Investments grew to $347.8 million in Q1 2026, from $319.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $486.0 million in Q4 2024 to a low of $23.2 million in Q2 2022.
• A 5-year average of $275.7 million and a median of $319.1 million in 2025 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments tumbled 85.99% in 2022 and jumped 710.15% in 2023, its largest moves.
• Tracing BHVN's Cash & Current Investments over 5 years: stood at $465.3 million in 2022, then decreased by 17.95% to $381.8 million in 2023, then gained by 27.28% to $486.0 million in 2024, then sank by 34.33% to $319.1 million in 2025, then increased by 8.99% to $347.8 million in 2026.
• Business Quant data shows BHVN's Cash & Current Investments at $347.8 million in Q1 2026, $319.1 million in Q4 2025, and $260.2 million in Q3 2025.